Profil
John Paolucci worked as a Marketing Director at Aratana Therapeutics, Inc. from 2013 to 2016.
He completed his undergraduate degree at Colorado School of Mines and his graduate and MBA degrees at The University of Texas at Austin.
Anciens postes connus de John Paolucci
| Sociétés | Poste | Fin |
|---|---|---|
| ARATANA THERAPEUTICS INC | Sales & Marketing | 01/07/2016 |
Formation de John Paolucci
| Colorado School of Mines | Undergraduate Degree |
| The University of Texas at Austin | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |